| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.78B | 1.75B | 1.71B | 1.24B | 960.84M |
| Gross Profit | 979.00M | 1.15B | 1.14B | 798.30M | 589.86M |
| EBITDA | 330.60M | 234.40M | 289.70M | 82.50M | 120.32M |
| Net Income | -547.50M | -192.00M | -56.40M | -120.60M | 67.31M |
Balance Sheet | |||||
| Total Assets | 2.10B | 2.67B | 2.75B | 2.95B | 539.71M |
| Cash, Cash Equivalents and Short-Term Investments | 264.30M | 265.40M | 258.46M | 339.20M | 264.02M |
| Total Debt | 1.89B | 1.83B | 1.75B | 1.79B | 30.88M |
| Total Liabilities | 2.77B | 2.77B | 2.67B | 2.79B | 371.90M |
| Stockholders Equity | -680.60M | -116.40M | 79.90M | 159.20M | 167.71M |
Cash Flow | |||||
| Free Cash Flow | 86.60M | 131.10M | 81.10M | -107.00M | 102.55M |
| Operating Cash Flow | 91.00M | 226.50M | 151.40M | -30.20M | 133.13M |
| Investing Cash Flow | -115.30M | -93.70M | -21.10M | -428.90M | -30.48M |
| Financing Cash Flow | -21.30M | -103.50M | -188.60M | 588.30M | -70.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £83.48M | 15.46 | 15.38% | ― | 10.22% | -33.00% | |
65 Neutral | £901.96M | 0.71 | 99.57% | 163.36% | ― | ― | |
64 Neutral | £462.81M | 13.70 | 9.03% | 2.58% | 5.13% | 6.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £3.49B | -5.30 | -57.07% | 2.24% | 3.34% | -47.20% | |
53 Neutral | £11.24M | 30.90 | ― | ― | ― | ― | |
51 Neutral | £209.06M | -0.39 | 125.82% | ― | 1.56% | -185.45% |